• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌动蛋白相关蛋白 2/3 复合物亚基 5(ARPC5)促进细胞迁移和侵袭,并且在头颈部鳞状细胞癌中受抑癌 microRNA-133a 的直接调控。

Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma.

机构信息

Department of Functional Genomics, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.

出版信息

Int J Oncol. 2012 Jun;40(6):1770-8. doi: 10.3892/ijo.2012.1390. Epub 2012 Feb 29.

DOI:10.3892/ijo.2012.1390
PMID:22378351
Abstract

Our expression signatures of human cancers including head and neck squamous cell carcinoma (HNSCC) demonstrated that downregulation of microRNA-133a (miR-133a) were frequently observed in cancer cells. The restoration of miR-133a in cancer cells revealed that it functions as a tumor suppressor. In this study, we investigated the novel molecular targets of miR-133a in HNSCC cancer cells and its oncogenic function, especially as it contributes to cancer cell migration and invasion. The genome-wide gene expression analysis and bioinformatics study showed that actin-related protein 2/3 complex subunit 5 (ARPC5) is a candidate target of miR-133a. Furthermore, luciferase reporter assay demonstrated that ARPC5 is directly regulated by miR-133a. Silencing of ARPC5 revealed significant inhibition of cell migration and invasion in HNSCC cell lines, SAS, HSC3 and IMC-3. In HSC3 cells, restoration of miR-133a or silencing ARPC5 led to a reorganization of the actin cytoskeleton and a subsequent change in cell morphology to a round, bleb-like shape. The expression levels of ARPC5 were significantly higher in HNSCC tissues than in non-cancer tissues. Immunohistochemistry showed that the levels of ARPC5 expression were significantly higher in invasive cancer cells. ARPC5 contributed to cancer cell migration and invasion in HNSCC and this gene was directly regulated by miR-133a. Our analysis of novel tumor-suppressive miR‑133a-mediated cancer pathways provides new insights into the potential mechanisms of HNSCC oncogenesis.

摘要

我们对包括头颈部鳞状细胞癌(HNSCC)在内的人类癌症的表达谱进行分析,结果表明 miR-133a 的下调在癌细胞中经常发生。在癌细胞中恢复 miR-133a 的功能表明它作为一种肿瘤抑制因子发挥作用。在这项研究中,我们研究了 miR-133a 在 HNSCC 癌细胞中的新的分子靶标及其致癌功能,特别是其对癌细胞迁移和侵袭的作用。全基因组基因表达分析和生物信息学研究表明,肌动蛋白相关蛋白 2/3 复合物亚基 5(ARPC5)是 miR-133a 的候选靶标。此外,荧光素酶报告基因检测表明 ARPC5 是受 miR-133a 直接调控的。沉默 ARPC5 显著抑制 HNSCC 细胞系 SAS、HSC3 和 IMC-3 的迁移和侵袭。在 HSC3 细胞中,恢复 miR-133a 或沉默 ARPC5 导致肌动蛋白细胞骨架的重排,并导致细胞形态发生后续变化,呈圆形、泡状。ARPC5 在 HNSCC 组织中的表达水平明显高于非癌组织。免疫组织化学显示,侵袭性癌细胞中 ARPC5 的表达水平明显升高。ARPC5 促进 HNSCC 中的癌细胞迁移和侵袭,该基因受 miR-133a 的直接调控。我们对新型肿瘤抑制 miR-133a 介导的癌症途径的分析为 HNSCC 致癌机制提供了新的见解。

相似文献

1
Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma.肌动蛋白相关蛋白 2/3 复合物亚基 5(ARPC5)促进细胞迁移和侵袭,并且在头颈部鳞状细胞癌中受抑癌 microRNA-133a 的直接调控。
Int J Oncol. 2012 Jun;40(6):1770-8. doi: 10.3892/ijo.2012.1390. Epub 2012 Feb 29.
2
Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma.抑瘤 microRNA-133a 调控肺鳞癌中的新型分子网络。
J Hum Genet. 2012 Jan;57(1):38-45. doi: 10.1038/jhg.2011.126. Epub 2011 Nov 17.
3
Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma.抑瘤微小 RNA-133a 调控新型靶标:原肌球蛋白参与头颈部鳞状细胞癌中癌细胞的增殖和侵袭。
Biochem Biophys Res Commun. 2012 Feb 10;418(2):378-83. doi: 10.1016/j.bbrc.2012.01.030. Epub 2012 Jan 12.
4
Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer.膀胱癌中肿瘤抑制因子 microRNA-1 和 microRNA-133a 调控的新型分子靶标。
Int J Oncol. 2012 Jun;40(6):1821-30. doi: 10.3892/ijo.2012.1391. Epub 2012 Feb 29.
5
Glutathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133α in head and neck squamous cell carcinoma (HNSCC).谷胱甘肽 S-转移酶 P1 (GSTP1) 抑制头颈部鳞状细胞癌 (HNSCC) 中的细胞凋亡及其受 miR-133α 的调控。
Int J Mol Med. 2011 Mar;27(3):345-52. doi: 10.3892/ijmm.2010.589. Epub 2010 Dec 22.
6
Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma.鉴定受抑癌 miR-1/miR-133a 调控的上颌窦鳞癌细胞中的新型分子靶标。
Int J Oncol. 2011 Nov;39(5):1099-107. doi: 10.3892/ijo.2011.1096. Epub 2011 Jun 23.
7
Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.LASP1 在细胞活力中的功能作用及其在膀胱癌中受 microRNAs 的调控。
Urol Oncol. 2012 Jul-Aug;30(4):434-43. doi: 10.1016/j.urolonc.2010.05.008. Epub 2010 Sep 16.
8
Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma.肿瘤抑制性微小RNA-218通过靶向层粘连蛋白-332抑制头颈部鳞状细胞癌的癌细胞迁移和侵袭。
Oncotarget. 2012 Nov;3(11):1386-400. doi: 10.18632/oncotarget.709.
9
The functional significance of miR-1 and miR-133a in renal cell carcinoma.miR-1 和 miR-133a 在肾细胞癌中的功能意义。
Eur J Cancer. 2012 Apr;48(6):827-36. doi: 10.1016/j.ejca.2011.06.030.
10
Repression of bone morphogenetic protein 4 by let-7i attenuates mesenchymal migration of head and neck cancer cells.Let-7i 抑制骨形态发生蛋白 4 可减轻头颈部癌细胞的间充质迁移。
Biochem Biophys Res Commun. 2013 Mar 29;433(1):24-30. doi: 10.1016/j.bbrc.2013.02.076. Epub 2013 Feb 26.

引用本文的文献

1
Elevated Fcy receptor expression augments pro-inflammatory macrophage phagocytosis in systemic sclerosis and associated rheumatic diseases.Fcγ受体表达升高增强了系统性硬化症及相关风湿性疾病中促炎性巨噬细胞的吞噬作用。
Rheumatology (Oxford). 2025 Jun 1;64(6):3975-3988. doi: 10.1093/rheumatology/keae688.
2
Comparative analysis of the exosomal contents of DF-1 cells infected by ALV-J.感染J亚群禽白血病病毒的DF-1细胞外泌体内容物的比较分析
Vet Med (Praha). 2022 Feb 15;67(2):87-98. doi: 10.17221/141/2020-VETMED. eCollection 2022 Feb.
3
ARPC5 acts as a potential prognostic biomarker that is associated with cell proliferation, migration and immune infiltrate in gliomas.
ARPC5作为一种潜在的预后生物标志物,与胶质瘤中的细胞增殖、迁移和免疫浸润相关。
BMC Cancer. 2023 Oct 3;23(1):937. doi: 10.1186/s12885-023-11433-w.
4
Analysis and validation of the potential of the MYO1E gene in pancreatic adenocarcinoma based on a bioinformatics approach.基于生物信息学方法对MYO1E基因在胰腺腺癌中的潜力进行分析与验证
Oncol Lett. 2023 May 19;26(1):285. doi: 10.3892/ol.2023.13871. eCollection 2023 Jul.
5
CPEB2 enhances cell growth and angiogenesis by upregulating ARPC5 mRNA stability in multiple myeloma.CPEB2 通过上调多发性骨髓瘤中 ARPC5 mRNA 的稳定性来促进细胞生长和血管生成。
J Orthop Surg Res. 2023 May 26;18(1):384. doi: 10.1186/s13018-023-03835-0.
6
MiR-145 regulates steroidogenesis in mouse primary granulosa cells by targeting Arpc5 and subsequent cytoskeleton remodeling.miR-145 通过靶向 Arpc5 及随后的细胞骨架重塑来调节小鼠初级颗粒细胞中的类固醇生成。
J Reprod Dev. 2023 Jun 6;69(3):154-162. doi: 10.1262/jrd.2022-137. Epub 2023 Apr 18.
7
ARPC5 is transcriptionally activated by KLF4, and promotes cell migration and invasion in prostate cancer via up-regulating ADAM17 : ARPC5 serves as an oncogene in prostate cancer.ARPC5 可被 KLF4 转录激活,并通过上调 ADAM17 促进前列腺癌中的细胞迁移和侵袭:ARPC5 是前列腺癌中的一种癌基因。
Apoptosis. 2023 Jun;28(5-6):783-795. doi: 10.1007/s10495-023-01827-3. Epub 2023 Mar 7.
8
ARPC1A correlates with poor prognosis in prostate cancer and is up-regulated by glutamine metabolism to promote tumor cell migration, invasion and cytoskeletal changes.ARPC1A与前列腺癌的不良预后相关,并且通过谷氨酰胺代谢上调,以促进肿瘤细胞迁移、侵袭和细胞骨架变化。
Cell Biosci. 2023 Feb 22;13(1):38. doi: 10.1186/s13578-023-00985-w.
9
ArpC5 isoforms regulate Arp2/3 complex-dependent protrusion through differential Ena/VASP positioning.ArpC5 异构体通过差异定位 Ena/VASP 调节 Arp2/3 复合物依赖性突出。
Sci Adv. 2023 Jan 20;9(3):eadd6495. doi: 10.1126/sciadv.add6495.
10
Zinc Fingers and Homeobox Family in Cancer: A Double-Edged Sword.锌指和同源盒家族在癌症中的作用:一把双刃剑。
Int J Mol Sci. 2022 Sep 22;23(19):11167. doi: 10.3390/ijms231911167.